GB2436873A - Blood glucose monitoring systems - Google Patents

Blood glucose monitoring systems Download PDF

Info

Publication number
GB2436873A
GB2436873A GB0606984A GB0606984A GB2436873A GB 2436873 A GB2436873 A GB 2436873A GB 0606984 A GB0606984 A GB 0606984A GB 0606984 A GB0606984 A GB 0606984A GB 2436873 A GB2436873 A GB 2436873A
Authority
GB
United Kingdom
Prior art keywords
blood glucose
glucose
time
insulin
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0606984A
Other languages
English (en)
Other versions
GB0606984D0 (en
Inventor
Roman Hovorka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge University Technical Services Ltd CUTS
Cambridge Enterprise Ltd
Original Assignee
Cambridge University Technical Services Ltd CUTS
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge University Technical Services Ltd CUTS, Cambridge Enterprise Ltd filed Critical Cambridge University Technical Services Ltd CUTS
Priority to GB0606984A priority Critical patent/GB2436873A/en
Publication of GB0606984D0 publication Critical patent/GB0606984D0/en
Priority to PCT/GB2007/050164 priority patent/WO2007116226A2/fr
Publication of GB2436873A publication Critical patent/GB2436873A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Ecology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
GB0606984A 2006-04-07 2006-04-07 Blood glucose monitoring systems Withdrawn GB2436873A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0606984A GB2436873A (en) 2006-04-07 2006-04-07 Blood glucose monitoring systems
PCT/GB2007/050164 WO2007116226A2 (fr) 2006-04-07 2007-03-28 Systèmes de surveillance de glucose sanguin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0606984A GB2436873A (en) 2006-04-07 2006-04-07 Blood glucose monitoring systems

Publications (2)

Publication Number Publication Date
GB0606984D0 GB0606984D0 (en) 2006-05-17
GB2436873A true GB2436873A (en) 2007-10-10

Family

ID=36539491

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0606984A Withdrawn GB2436873A (en) 2006-04-07 2006-04-07 Blood glucose monitoring systems

Country Status (2)

Country Link
GB (1) GB2436873A (fr)
WO (1) WO2007116226A2 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010105743A1 (fr) * 2009-03-16 2010-09-23 Roche Diagnostics Gmbh Procédé de production automatique d'un régime de collecte de données de mesure spécifique à l'utilisateur pour une mesure discontinue de la glycémie, ainsi que dispositif de traitement de données et appareil de mesure de la glycémie
DE102009024229B3 (de) * 2009-06-08 2010-10-14 Salzsieder, Eckhard, Dipl.-Phys., Dr. rer.nat. Indikationseinrichtung zur automatisierten Bestimmung des individuellen Inkretin-Sensitivitäts-Indexes eines Probanden
EP2243423A1 (fr) * 2009-04-23 2010-10-27 Roche Diagnostics GmbH Procédé et appareil de détermination de conseils pour dosages de matière active à l'aide de séries de mesures d'au moins un paramètre physiologique d'un patient
AU2008309313B2 (en) * 2007-10-12 2012-06-28 Cambridge Enterprise Limited Substance monitoring and control in human or animal bodies
FR3056095A1 (fr) * 2016-09-21 2018-03-23 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
FR3056094A1 (fr) * 2016-09-21 2018-03-23 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
WO2019016452A1 (fr) * 2017-07-21 2019-01-24 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
WO2020128387A1 (fr) * 2018-12-21 2020-06-25 Commissariat A L'energie Atomique Et Aux Energies Alternatives Système automatisé de régulation de la glycémie d'un patient

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8956291B2 (en) 2005-02-22 2015-02-17 Admetsys Corporation Balanced physiological monitoring and treatment system
DE502007004737D1 (de) 2007-10-16 2010-09-23 Roche Diagnostics Gmbh Verfahren zur Speicherung einer Messreihe
CN103400028B (zh) 2008-04-04 2017-04-12 海吉雅有限公司 用于优化患者的胰岛素剂量方案的装置
US9220456B2 (en) 2008-04-04 2015-12-29 Hygieia, Inc. Systems, methods and devices for achieving glycemic balance
US10624577B2 (en) 2008-04-04 2020-04-21 Hygieia, Inc. Systems, devices, and methods for alleviating glucotoxicity and restoring pancreatic beta-cell function in advanced diabetes mellitus
WO2010056718A2 (fr) 2008-11-11 2010-05-20 Hygieia, Inc. Appareil et système de gestion du diabète
EP2413781B1 (fr) 2009-03-31 2019-07-24 Abbott Diabetes Care Inc. Administration d'insuline en boucle fermée pendant toute une nuit avec commande prédictive à modèle et modèle d'erreur de mesure de glucose
PL2482870T3 (pl) 2009-09-29 2018-05-30 Admetsys Corporation System i sposób rozróżniania pojemników w podawaniu leków
JP6084568B2 (ja) * 2011-09-27 2017-02-22 テルモ株式会社 アナライトモニタシステム
EP2844134A4 (fr) * 2012-04-30 2016-01-06 Mimar Lp Dispositif et procédé de surveillance interactive basée sur des éléments probants
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9233204B2 (en) 2014-01-31 2016-01-12 Aseko, Inc. Insulin management
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
EP3050023B1 (fr) 2014-10-27 2021-08-25 Aseko, Inc. Gestion sous-cutanée de patient externe
CA2993275C (fr) 2015-08-20 2022-06-21 Aseko, Inc. Conseiller de therapie pour la gestion du diabete
MA45580A (fr) 2016-07-08 2019-05-15 Novo Nordisk As Titrage basal avec glycémie cible adaptative
MA46048A (fr) 2016-08-25 2019-07-03 Novo Nordisk As Kit de débutant pour le titrage de l'insuline de base
CN110012675B (zh) 2016-11-29 2024-02-27 诺和诺德股份有限公司 用于基础率滴定的起始套件
JP6874155B2 (ja) 2017-05-05 2021-05-19 イーライ リリー アンド カンパニー 生理的グルコースの閉ループ制御
WO2019125932A1 (fr) 2017-12-21 2019-06-27 Eli Lilly And Company Régulation en boucle fermée de glucose physiologique
CN109171754B (zh) * 2018-07-27 2022-07-05 清华-伯克利深圳学院筹备办公室 血糖预测模型的训练方法、装置、终端及存储介质
WO2022011345A1 (fr) * 2020-07-10 2022-01-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Kits et procédés de mesure de la sensibilité à l'insuline

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840020A (en) * 1996-02-12 1998-11-24 Nokia Mobile Phones, Ltd. Monitoring method and a monitoring equipment
EP0881495A1 (fr) * 1997-05-30 1998-12-02 Nokia Mobile Phones Ltd. ContrÔle du diabète
US6017318A (en) * 1995-02-07 2000-01-25 Gensia Automedics, Inc. Feedback controlled drug delivery system
WO2001083007A2 (fr) * 2000-05-03 2001-11-08 Aspect Medical Systems, Inc. Systeme et procede d'administration adaptee de medicament
US20030130616A1 (en) * 1999-06-03 2003-07-10 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
WO2003080157A1 (fr) * 2002-03-22 2003-10-02 K. U. Leuven Research And Development Systeme de perfusion automatique reposant sur un modele adaptatif de patient
US20040152622A1 (en) * 2002-10-11 2004-08-05 Steven Keith System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device
WO2006011869A2 (fr) * 2004-06-28 2006-02-02 Paul M Rosman Traitement predictif d'ecarts dysglycemiques associes au diabete sucre

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436094A (en) 1981-03-09 1984-03-13 Evreka, Inc. Monitor for continuous in vivo measurement of glucose concentration
US4704029A (en) 1985-12-26 1987-11-03 Research Corporation Blood glucose monitor
EP1292324A2 (fr) 2000-05-05 2003-03-19 Novo Nordisk A/S Neurophaties en maladies graves
JP2007512588A (ja) * 2003-10-29 2007-05-17 ノボ・ノルデイスク・エー／エス 医療助言システム

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017318A (en) * 1995-02-07 2000-01-25 Gensia Automedics, Inc. Feedback controlled drug delivery system
US5840020A (en) * 1996-02-12 1998-11-24 Nokia Mobile Phones, Ltd. Monitoring method and a monitoring equipment
EP0881495A1 (fr) * 1997-05-30 1998-12-02 Nokia Mobile Phones Ltd. ContrÔle du diabète
US20030130616A1 (en) * 1999-06-03 2003-07-10 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
WO2001083007A2 (fr) * 2000-05-03 2001-11-08 Aspect Medical Systems, Inc. Systeme et procede d'administration adaptee de medicament
WO2003080157A1 (fr) * 2002-03-22 2003-10-02 K. U. Leuven Research And Development Systeme de perfusion automatique reposant sur un modele adaptatif de patient
US20040152622A1 (en) * 2002-10-11 2004-08-05 Steven Keith System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled to a single-needle or multi-needle intradermal (ID) delivery device
WO2006011869A2 (fr) * 2004-06-28 2006-02-02 Paul M Rosman Traitement predictif d'ecarts dysglycemiques associes au diabete sucre

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008309313B2 (en) * 2007-10-12 2012-06-28 Cambridge Enterprise Limited Substance monitoring and control in human or animal bodies
US8977504B2 (en) 2007-10-12 2015-03-10 Cambridge Enterprise Limited Substance monitoring and control in human or animal bodies
WO2010105743A1 (fr) * 2009-03-16 2010-09-23 Roche Diagnostics Gmbh Procédé de production automatique d'un régime de collecte de données de mesure spécifique à l'utilisateur pour une mesure discontinue de la glycémie, ainsi que dispositif de traitement de données et appareil de mesure de la glycémie
CN102428468A (zh) * 2009-03-16 2012-04-25 霍夫曼-拉罗奇有限公司 自动产生用于不连续的血糖测量的用户专属测量记录例程的方法以及数据处理装置和血糖测量装置
CN102428468B (zh) * 2009-03-16 2016-10-26 霍夫曼-拉罗奇有限公司 自动产生用于不连续的血糖测量的用户专属测量记录例程的方法以及数据处理装置和血糖测量装置
US9703930B2 (en) 2009-03-16 2017-07-11 Roche Diabetes Care, Inc. Automatic user-specific spot BG measuring routine based on user continuous BG measurements
EP2243423A1 (fr) * 2009-04-23 2010-10-27 Roche Diagnostics GmbH Procédé et appareil de détermination de conseils pour dosages de matière active à l'aide de séries de mesures d'au moins un paramètre physiologique d'un patient
DE102009024229B3 (de) * 2009-06-08 2010-10-14 Salzsieder, Eckhard, Dipl.-Phys., Dr. rer.nat. Indikationseinrichtung zur automatisierten Bestimmung des individuellen Inkretin-Sensitivitäts-Indexes eines Probanden
FR3056095A1 (fr) * 2016-09-21 2018-03-23 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
FR3056094A1 (fr) * 2016-09-21 2018-03-23 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
WO2018055283A1 (fr) * 2016-09-21 2018-03-29 Commissariat A L'energie Atomique Et Aux Energies Alternatives Système automatise de régulation de la glycémie d'un patient
WO2018055284A1 (fr) * 2016-09-21 2018-03-29 Commissariat A L'energie Atomique Et Aux Energies Alternatives Système automatise de régulation de la glycémie d'un patient
US11213249B2 (en) 2016-09-21 2022-01-04 Commissariat à l'énergie atomique et aux énergies alternatives Automated system for controlling the blood glucose level of a patient
US11298460B2 (en) 2016-09-21 2022-04-12 Commissariat à l'énergie atomique et aux énergies alternatives Automated system for controlling the blood glucose level of a patient
EP4265183A1 (fr) 2016-09-21 2023-10-25 Commissariat à l'énergie atomique et aux énergies alternatives Système automatisé de régulation de la glycémie d'un patient
WO2019016452A1 (fr) * 2017-07-21 2019-01-24 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
US11433184B2 (en) 2017-07-21 2022-09-06 Commissariat à l'énergie atomique et aux énergies alternatives Automated system for regulating a patient's blood glucose level
WO2020128387A1 (fr) * 2018-12-21 2020-06-25 Commissariat A L'energie Atomique Et Aux Energies Alternatives Système automatisé de régulation de la glycémie d'un patient
FR3090315A1 (fr) * 2018-12-21 2020-06-26 Commissariat A L'energie Atomique Et Aux Energies Alternatives Système automatisé de régulation de la glycémie d'un patient

Also Published As

Publication number Publication date
GB0606984D0 (en) 2006-05-17
WO2007116226A3 (fr) 2008-03-13
WO2007116226A2 (fr) 2007-10-18

Similar Documents

Publication Publication Date Title
GB2436873A (en) Blood glucose monitoring systems
US11723562B2 (en) Method, system and computer program product for CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery
Blauw et al. A review of safety and design requirements of the artificial pancreas
Huyett et al. Design and evaluation of a robust PID controller for a fully implantable artificial pancreas
CN105592873B (zh) 用于控制归因于人工胰腺中的闭环控制器的传感器替换的调谐因子的方法和系统
JP6312696B2 (ja) 人工膵臓の閉ループコントローラ調整のための方法及びシステム
JP6243546B2 (ja) 先行する期間に基づくオフライングルコースレベル制御
RU2641976C2 (ru) Способ и система обработки ручного болюсного введения или введения в соответствии с приемом пищи в контроллерах с обратной связью
US9089305B2 (en) Substance monitoring and control in human or animal bodies
US10420489B2 (en) System coordinator and modular architecture for open-loop and closed-loop control of diabetes
León-Vargas et al. Postprandial blood glucose control using a hybrid adaptive PD controller with insulin-on-board limitation
Lee et al. Enhanced model predictive control (eMPC) strategy for automated glucose control
TW201503921A (zh) 用於人工胰臟之混合式控制至目標及控制至範圍模型預測控制的方法及系統
US11430557B2 (en) System and method for improving the drug therapy management
WO2015056259A1 (fr) Système et procédé pour une gestion améliorée de pancréas artificiel
Nath et al. Physiological models and control for type 1 diabetes mellitus: a brief review
Turksoy et al. Automated insulin delivery—the light at the end of the tunnel
Szalay et al. The significance of LPV modeling of a widely used T1DM model
Horwitz et al. New technologies for glucose monitoring and insulin administration
Kovács et al. Quasi in-silico validations of a nonlinear LPV model-based robust glucose control algorithm for type i diabetes
Dadlani et al. Continuous glucose monitor use and accuracy in hospitalized patients
Rodríguez-Sarmiento et al. A constrained robust Markovian control approach with robust Kalman filter for fully automated insulin delivery systems
Podchasov Development of Failure Model for Reliability Increment of Automated Mechatronical Insulin Pumps
Zhou et al. An in-silico Study of Using Continuous Glucose Monitoring Measures for Glycaemic Control in the ICU.
Huang et al. A Dynamic Model with Structured Recurrent Neural Network to Predict Glucose-Insulin Regulation of Type 1 Diabetes Mellitus

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)